fbpx

15th Annual Congress on Controversies in Ophthalmology (COPHy 2024)

Find Out More

Resources

Feb 20, 2024

February is Low Vision Month

February is Low Vision Month   There are a few ways to define low vision. I think of it as having vision that is not good enough to perform activities…

February is Low Vision Month

Feb 14, 2024

Happy Valentine’s Day

Happy Valentines Day Show your eyes some love- schedule your eye exam today.

Happy Valentine’s Day

Feb 12, 2024

Macular Degeneration Month

Reviewed by Jeffry Gerson, OD, FAAO Macular degeneration is the leading cause of vision loss. This disease affects approximately 20 million people in the United States, and nearly 1.5 million…

Macular Degeneration Month

Feb 6, 2024

FDA warns consumers of contaminated copycat eye drops

    by, David Hutton, Managing Editor, Ophthalmology Times In a news release, the FDA noted these are copycat eye drop products that consumers can easily mistake for Bausch +…

FDA warns consumers of contaminated copycat eye drops

Jan 26, 2024

Geographic Atrophy: Partnering Together for Best Patient Outcomes

by: Jeffry Gerson, OD, FAAO Medical Director for the Macular Degeneration Association                                     …

Geographic Atrophy: Partnering Together for Best Patient Outcomes

Jan 22, 2024

January Is Glaucoma Awareness Month

Two Compelling Cases of Significant IOP Reduction in Advanced Glaucoma Recent breakthroughs in minimally invasive glaucoma treatment are reshaping the approach to managing this disease. One standout innovation, the iStent…

January Is Glaucoma Awareness Month

Jan 22, 2024

Ocular gene therapy: The good, the bad, and the maybe

David Eichenbaum, MD, discussed the status of the technology at the Retina 2024 meeting in Maui. Ocular gene therapy is not yet ready for prime time, according to David Eichenbaum,…

Ocular gene therapy: The good, the bad, and the maybe

Jan 18, 2024

Eye Health in Elderly

          By: You Loong Yeong, OD Our eyes undergo natural changes as we age, and the risk of certain eye diseases increases. This infographic provides a…

Eye Health in Elderly

Jan 18, 2024

Producing tears in a dish: Researchers develop first model of human conjunctiva

Published January 12, 2024 | Originally published on MedicalXpress Breaking News-and-Events The Organoid group at the Hubrecht Institute produced the first organoid model of the human conjunctiva. These organoids mimic the function of the…

Producing tears in a dish: Researchers develop first model of human conjunctiva

Jan 17, 2024

Early Cognitive Decline: Can Eye Doctors Mitigate the Risk Through Lifestyle and Vision Interventions?

By Julie Poteet, OD, MS, CNS, FOWNS According to current statistics, one in every 10 people will have Alzheimer’s dementia by the time they are 65 years old. That risk will…

Early Cognitive Decline: Can Eye Doctors Mitigate the Risk Through Lifestyle and Vision Interventions?

Jan 2, 2024

Eye health nutrients: Which ingredients help with dry eye and blue light?

Published on: January 2, 2024 Gene Bruno, MS, MHS, RH(AHG) A look at lutein, zeaxanthin, astaxanthin, β-cryptoxanthin, capsanthin, and palmitoleic acid. Eye health supplements are a category of significant interest. According…

Eye health nutrients: Which ingredients help with dry eye and blue light?

Jan 2, 2024

Report: Age-related eye diseases raise risk for falls, fractures

by: KRISTEN FISCHER Older adults who have cataract, age-related macular degeneration (AMD) or glaucoma are at a higher risk for falls and fractures, according to a new study. Glaucoma raises an individual’s…

Report: Age-related eye diseases raise risk for falls, fractures

Jan 2, 2024

Signs and Symptoms of Macular Degeneration

By: Mark Gurarie Updated on January 2, 2024  Medically reviewed by: Christine L. Larsen, MD Age-related macular degeneration (AMD), often known as just macular degeneration, is a type of vision…

Signs and Symptoms of Macular Degeneration

Dec 31, 2023

Happy New Year

We are wishing everyone a Very Happy and Healthy New Year. The offices are currently closed and will reopen on Tuesday, January 2nd @ 8:00 am.

Happy New Year

Dec 25, 2023

Merry Christmas

The Macular Degeneration Association would like to wish everyone a very Merry Christmas. Our offices will be closed Monday, December 25th through Monday, January 1st. We will reopen on Tuesday,…

Merry Christmas

Dec 18, 2023

Seeing AI- Now on Android

Now on Android

Seeing AI- Now on Android

Dec 18, 2023

Human eyes: How they work, and their mind-blowing anatomy

Our eyes are crucially important in so many ways, but they are also incredibly complicated. By: Hayley Bennett Published: December 17, 2023 at 5:39 am Containing more than 100 million…

Human eyes: How they work, and their mind-blowing anatomy

Nov 27, 2023

#Giving Tuesday 2023

On Tuesday, November 28, 2022, from 12 am to 11:59 pm the MACULAR DEGENERATION ASSOCIATION is participating in the #GivingTuesday Campaign. Your donation will be maximized if you donate during this time…

#Giving Tuesday 2023

Nov 23, 2023

Happy Thanksgiving

  Happy Thanksgiving to you and yours. “As we express our gratitude, we must never forget that the highest appreciation is not to utter words, but to live by them.”…

Happy Thanksgiving

Nov 15, 2023

Spotlight on Thyroid Eye Disease

November 13 – 19 is Thyroid Eye Disease Awareness Week. What is thyroid eye disease (TED)? TED is an autoimmune disease in which the eye muscles and fatty tissue behind the…

Spotlight on Thyroid Eye Disease

Oct 20, 2023

Eye implant may be used to treat diabetes and other diseases

Published October 19, 2023 | Originally published on MedicalXpress Breaking News-and-Events Researchers in Sweden have developed a microscale device for implantation in the eye, which presents new opportunities for cell-based treatment of diabetes and…

Eye implant may be used to treat diabetes and other diseases

Oct 17, 2023

(Podcast) Confronting Demodex blepharitis: From rude awakening to FDA-approved solutio

Peter J. McDonnell, MD Neda Shamie, MD In this podcast episode, Ophthalmology Times’ co-chief medical editors Peter J. McDonnell, MD, and Neda Shamie, MD, delve into the clinical nuances of…

(Podcast) Confronting Demodex blepharitis: From rude awakening to FDA-approved solutio

Oct 12, 2023

Wet Macular Degeneration Research Opportunity

Research Opportunity for Wet Macular Degeneration Patients currently living in The United States. This is a 60-minute web-assisted phone interview via Zoom. Compensation is $120. Please sign up at the link below for more information…

Wet Macular Degeneration Research Opportunity

Sep 13, 2023

Researchers find link between sleep duration and development of type 2 diabetes, despite other lifestyle factors

Researchers find a link between sleep duration and the development of type 2 diabetes, despite other lifestyle factors A team of medical researchers with a diverse mix of backgrounds, all…

Researchers find link between sleep duration and development of type 2 diabetes, despite other lifestyle factors

Sep 13, 2023

Bausch + Lomb launches MIEBO (perfluorohexyloctane ophthalmic solution) in US

David Hutton, Managing Editor, Ophthalmology Times Bausch + Lomb Corp. announced the US commercial launch of perfluorohexyloctane ophthalmic solution (Miebo) for treatment of the signs and symptoms of dry eye disease…

Bausch + Lomb launches MIEBO (perfluorohexyloctane ophthalmic solution) in US

Sep 11, 2023

Ocular allergies and dry eye disease: Overlapping treatment options

Euin Cheong, OD Dual-purpose therapeutics help patients with both conditions.

Ocular allergies and dry eye disease: Overlapping treatment options

Sep 11, 2023

Diabetics, rejoice: For some, an extra cup of coffee might be just what the doctor ordered

Diabetics, rejoice: For some, an extra cup of coffee might be just what the doctor ordered By Anastasia Climan, RDN, CD-N | Fact-checked by Barbara Bekiesz Published September 5, 2023 Key Takeaways Coffee has several bioactive…

Diabetics, rejoice: For some, an extra cup of coffee might be just what the doctor ordered

Aug 21, 2023

Regeneron Pharmaceuticals receive FDA approval for Eylea HD

August 18, 2023, EYLEA HD (AFLIBERCEPT) INJECTION 8 MG APPROVED BY FDA FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION (WAMD), DIABETIC MACULAR EDEMA (DME) AND DIABETIC RETINOPATHY (DR) Approval based…

Regeneron Pharmaceuticals receive FDA approval for Eylea HD

Aug 14, 2023

Wet AMD Outcomes Through the Years

 

Wet AMD Outcomes Through the Years

Aug 8, 2023

Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy

NEWS PROVIDED BY Astellas Pharma Inc. 04 Aug 2023, 21:24 ET IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month…

Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.